No featured image available
Congressional candidates are targeting lawmakers who received massive donations from drug companies while backing legislation that makes it more difficult for government agencies to tackle the opioid crisis.
A handful of political candidates are crusading against many of the politicians who backed legislation defanging the government’s ability to stanch the flow of unchecked opioids. They are turning the issues into a referendum against lawmakers who were bankrolled by pharmaceutical companies.
Jason Crow, a Democrat and U.S. Army combat veteran, for one, is planning on using the issue against Republican Rep. Mike Coffman of Colorado, who accepted $44,000 in donations from drug distributors and pharmacy companies.
“I’m a parent, and I’m raising kids in a community and country that is awash in drugs,” Crow told The Washington Post Monday. “If that doesn’t keep every parent up at night, then I don’t know what does. I’m done with that, and I’m not putting up with it anymore, and that’s what this election is about.”
He’s not the only candidate teeing off against Republicans and Democrats who supported legislation favoring the industry. Democratic candidate Judy Herschel launched a full-time congressional campaign against Republican Rep. Tom Marino of Pennsylvania, who she believes spearheaded legislation hampering the Drug Enforcement Administration’s enforcement efforts against the industry.
“It’s a big reason why I chose to run,” she said in April during a stump speech in a neighborhood not far from Williamsport, a city reeling from an inundation of pain pills and heroin. Marino’s Republican challenger in Tuesday’s primary Doug McLinko, a county commissioner, suggested Marino “sold out his office to the drug companies.”
Twenty-six lawmakers sponsored or co-sponsored versions of the Ensuring Patient Access and Effective Drug Enforcement Act in the House and the Senate, 23 of them Republicans, three of them Democrats. Several of the lawmakers are retiring, but 12 Republicans and all three Democrats are running for reelection or seeking higher office.
Drug distribution companies and pharmacy chains pushed the Ensuring Patient Access and Effective Drug Enforcement Act to counter aggressive DEA enforcement actions against the widespread, unchecked, distribution of drugs like OxyContin. The agency targeted the industry for failing to report suspicious orders of opioids. The market was effectively owned by two massive pharmaceutical firms.
The Sackler family and Purdue Pharma, which is widely blamed for playing an essential role in starting the epidemic, have given more than $1.3 million to U.S. candidates and another $1 million to political organizations since OxyContin’s creation, according to Center for Responsive Politics data, but that’s just the surface of how deep the pharmaceutical titans’ influence runs. (RELATED: American Cartel: Here Are The Politicians That Took Opioid Tycoons’ ‘Dirty, Bloody Money’)
Republican Rep. Gus M. Bilirakis of Florida is another co-sponsor. He held between $4,000 and $60,000 in Rite Aid stock, according to the company’s financial disclosures, and accepted $77,500 from drug distribution and pharmacy companies.
Follow Chris White on Facebook and Twitter.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].